Legend Capital

Legend Capital, established in 2001 and based in Beijing, China, is a prominent venture capital firm and a subsidiary of Legend Holdings Ltd. The firm focuses on investing in high-growth ventures primarily within China or related markets, managing approximately US$700 million across multiple funds. Legend Capital emphasizes early-stage investments in the information technology sector, particularly in network applications and services, as well as in infrastructure and professional services. Additionally, it targets mid-market growth companies in consumer goods, clean technology, healthcare, equipment manufacturing, and modern services. With a portfolio of over 60 companies, Legend Capital actively supports its investments by providing extensive business resources and tailored services, aimed at enhancing business development and brand building in the Chinese market.

Daqing Cai

Managing Director

Hao Chen

Managing Director and Head of Investment

Raymond CHEN

Co-Chief Investment Officer

Rui Chen

Managing Director

Frank Hong

Managing Director

Henry Ji

Executive Director

Yi Kang

Director

Richard Li

President

Jiaqing Li

Managing Director

Xiangyu Ouyang

Managing Director

Joon Sung Park

Executive Director

FAN Qihui

Executive Director

Jenking Shao

Managing Director and Partner

Zhenxing Shao

Partner / Managing Director

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Piau-Voon Wang

COO

Tony WANG

VP

Ge Xinyu

Managing Director

Quan Zhou

Managing Director, Partner

Hank Zhou

Executive Director

Hongbin Zhou

Managing Director

William Wen

Executive Director

Past deals in Series B

Volant Aerotech

Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Angitia Biopharmaceuticals

Series B in 2023
Angitia Biopharmaceuticals is a global biotechnology company dedicated to discovering and developing innovative therapeutics for serious musculoskeletal diseases. The company focuses on researching and creating breakthrough therapies aimed at treating conditions affecting bones, muscles, and joints. By prioritizing the development of novel drugs, Angitia Biopharmaceuticals aims to improve patient outcomes and facilitate recovery from severe musculoskeletal ailments.

Zhipu AI

Series B in 2023
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.

Tailan New Energy

Series B in 2023
Tailan New Energy is co-founded by lithium battery R&D experts introduced by the national high-level overseas talent project and a senior domestic industrialization team, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.

Open Source China

Series B in 2023
Open Source China is a prominent community focused on open source technology, providing a platform for IT developers to discover, utilize, and exchange open source software. The community offers various resources, including open source software libraries, code sharing, discussion forums, and collaborative translation services. It serves as a hub for technical support, allowing users to seek answers to software-related questions and access relevant information. By fostering collaboration and knowledge sharing, Open Source China promotes the development and application of open source technologies among domestic developers, enhancing their ability to innovate and improve these technologies.

DentaFilm

Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

Rongke Power

Series B in 2023
Rongke Power offers production services for energy storage battery equipment. They sell items from the VPower, TPower, and UPowertm ranges, among other product lines. is a provider of services and a fully independent intellectual property right.

Shuhai Supply Chain

Series B in 2022
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.

APTBIO

Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

Joymed Technology

Series B in 2022
JoyMed Technology specializes in the research and development, registration, and manufacturing of medical devices, offering comprehensive solutions to medical equipment manufacturers. The company focuses on creating innovative and reliable technologies while ensuring high-quality product standards. By providing services such as device design, risk management, marketing, and product verification and validation, JoyMed Technology helps clients streamline their processes and reduce time to market. The firm aims to be a trusted partner for both domestic and international medical device companies, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through a flexible cooperation model and experienced team design, JoyMed Technology seeks to foster mutual growth with its customers.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

ZHIYI TECH

Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics is a biotechnology company based in Suzhou, China, specializing in the development of next-generation antibody-drug conjugates (ADCs). The company aims to address significant unmet medical needs in China by creating innovative therapeutics that target cancer while minimizing damage to healthy cells. MediLink Therapeutics is committed to enhancing patient outcomes through its research and development efforts, which include conducting multicenter clinical trials and engaging in cross-border collaborations to generate global value. By focusing on ADCs, the company strives to improve the efficacy of cancer treatments while ensuring patient safety during therapy.

Inceptio Technology

Series B in 2022
Inceptio Technology, founded in 2018 and based in Shanghai, China, specializes in the development of autonomous driving trucks aimed at transforming line-haul logistics. The company offers a nationwide freight network and provides a Transportation-As-A-Service model that enhances the security, efficiency, and cost-effectiveness of logistics operations. Utilizing advanced technologies such as artificial intelligence, new energy solutions, and logistics big data, Inceptio's heavy-duty trucks deliver innovative and safe logistics solutions tailored for logistics companies. Additionally, the company has established research and development centers in both Shanghai and Silicon Valley to further its technological advancements.

Zhipu AI

Series B in 2022
Zhipu AI is a data company focused on developing an AI-based large model platform that offers API services tailored to various customer needs. The company provides a range of smart application products, including the scientific and technological information analysis engine "AMiner" and AI cognitive engines such as CodeGeeX and CogView. These tools are designed to help users automate and optimize digital tasks, thereby reducing the required manual labor. Zhipu AI's advanced applications are built on its General Language Model (GLM) series, capable of handling tasks in both Chinese and English, making its offerings versatile and applicable across different linguistic contexts.

Singlomics

Series B in 2022
Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Xbiome

Series B in 2021
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

LePure Biotech

Series B in 2021
Lechun Biology is an enterprise engaged in disposable products and leak detection equipment in the biotechnology and pharmaceutical industries. The company develops and produces disposable biopharmaceutical process equipment and consumables. The products are used for the storage, transportation, filling and leak detection of various samples in biosimilars, vaccines and other biopharmaceutical processes. The core product is a disposable storage bag. Recently completed B+ round of financing. This round of financing will be mainly used for the development of a number of innovative new products, the establishment of a US R&D center, the integration of the upstream industrial chain, the securing of the supply chain, and the expansion of the R&D market operation team at home and abroad.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, specializing in research and development services that support drug discovery. Founded in 2009, the company offers a range of services, including recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus Biosciences is recognized for its commitment to quality and innovation, having established five advanced research platforms that enhance its capabilities in drug development. The company’s R&D team has developed various innovative techniques, some of which have been patented, further solidifying its role in the biotechnology sector. It operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.

ForQaly

Series B in 2021
ForQaly specializes in the development of minimally invasive ventricular assist devices designed to treat heart failure patients. The company focuses on creating therapeutic devices that enhance circulation while ensuring affordability for patients. Their products are characterized by features such as reduced trauma, high auxiliary flow, and user-friendly design, providing healthcare professionals with effective solutions for improving patient health. By combining innovation with accessibility, ForQaly aims to address the clinical needs of patients suffering from heart conditions.

HC Scientific

Series B in 2021
HC Scientific (Chengdu) L.L.C., founded in early 2016, focuses on developing intelligent solutions within the life sciences sector. The company aims to be a trusted partner for global clients by offering innovative products, including genetic testing instruments, reagents, and software. These products are primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is recognized as a national high-tech enterprise, emphasizing autonomous research and the development of intellectual property. The company participates in significant national and provincial scientific initiatives and is supported by a team of experts, including returning PhDs. Its product offerings streamline complex tasks for life science practitioners, delivering high-throughput, automated, and cost-effective genetic testing solutions while creating value for collaborative partners.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Berry Oncology

Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

YEASEN Biotechnology

Series B in 2021
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.

Bloks Technology Group

Series B in 2021
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bloks Group strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Dearer Medical

Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company emphasizes research and development to create both practical and fashionable color contact lenses, catering to a diverse customer base. Through its innovative approach, Dearer Medical aims to enhance the user experience while addressing the aesthetic and functional needs of contact lens wearers.

Fiture Technology

Series B in 2021
Fiture, a fitness technology company, is redefining the home fitness scenarios through intelligent hardware and AI-empowered fitness content.

StoneWise

Series B in 2021
StoneWise is a technology company established in 2018 that focuses on enhancing the drug discovery process through artificial intelligence. The company aims to transform traditional drug research and development by implementing a dual-engine model that combines advanced AI technology with expert systems. Its platform utilizes cutting-edge technologies, including microfluidics, computational chemistry, computational biology, pharmacology, and clinical medicine, to offer integrated solutions for pharmaceutical companies. These solutions encompass a variety of tools, such as medical knowledge graphs, molecular generation and design, and predictions of reaction products and synthetic pathways. By leveraging this innovative platform, StoneWise seeks to improve the efficiency and success rates of early-stage drug discoveries. The company collaborates with both domestic and international experts in various scientific fields, and maintains a state-of-the-art facility to stay abreast of the latest advancements in drug discovery.

Sciwind Biosciences

Series B in 2021
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Jinqirui Biology

Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Xbiome

Series B in 2020
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.

Aqrose Technology

Series B in 2020
Aqrose Technology Co., Ltd., founded in 2017 from the AI Lab of Tsinghua University, specializes in the application of advanced artificial intelligence and machine vision technologies in industrial settings. The company provides a range of products, including its standardized intelligent industrial vision platform AIDI and the AIPICK intelligent inspecting and sorting robot, which utilize 3D vision technology for automation. Aqrose's solutions support various sectors such as consumer electronics, automotive, new energy, pharmaceuticals, semiconductors, and logistics, enhancing manufacturing processes and product quality. With deployments in over 100 factories, including leading enterprises in advanced manufacturing and smart logistics, Aqrose is committed to empowering its clients through innovative technology.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

HEMO BIOENGINEERING

Series B in 2020
HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

Leadrive

Series B in 2020
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance domestic power semiconductor modules. The company develops advanced motor controllers and power modules tailored for new energy vehicles, which have been adopted by over ten models from leading domestic and international OEMs and Tier-1 suppliers. In addition to its focus on vehicle technology, LEADRIVE invests in innovative solutions for renewable energy sources, including wind and solar power, and energy storage systems. The company has achieved significant advancements in localizing power semiconductor modules and collaborates with Rohm Semiconductor to enhance the development of silicon carbide modules. This partnership aims to improve efficiency and performance across various applications, from semiconductor devices to vehicle-level integration.

Haihe Biopharma

Series B in 2020
Haihe Biopharma is dedicated to the discovery, development, and commercialization of innovative anti-tumor drugs aimed at addressing complex diseases. The company specializes in pharmacological efficacy evaluation and offers a range of products, including novel topoisomerase I inhibitors and highly selective oral c-Met inhibitors. By focusing on these advancements, Haihe Biopharma seeks to enhance health outcomes for patients and improve the quality of research in the pharmaceutical field.

ESWIN Computing

Series B in 2020
ESWIN Computing specializes in the research and development of RISC-V computing architecture, focusing on the design and testing of integrated circuits for Internet of Things (IoT) applications. The company develops chips used in display devices and wearable technology, providing comprehensive solutions in areas such as artificial intelligence, human-computer interaction, and the Internet of Vehicles. By combining innovative design with advanced materials, ESWIN Computing aims to enhance user experiences across various digital platforms.

Uditech

Series B in 2020
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

iBeiDiao

Series B in 2020
iBeiDiao is an intelligent employee background investigation service-providing company. They provide objective background-checking services and employee onboarding management solutions for employees using artificial intelligence, providing employee credit reference information for enterprises.

Wangdiantong

Series B in 2020
Wangdiantong ERP is a provider of enterprise-level e-commerce solutions that facilitate the integration of online and offline retail operations. The company's services encompass a range of functionalities, including inventory management, order processing, purchasing, after-sales service, and customer relationship management. By supporting major platforms such as Taobao, Tmall, Jingdong, Amazon, and Alibaba, Wangdiantong enables businesses to effectively manage multi-warehouse systems and streamline operations for both online stores and physical retail locations. Additionally, the company offers intelligent warehouse solutions and cloud-based services designed to assist enterprises in transitioning to digital management and scaling their operations efficiently.

Healing Paper

Series B in 2020
Healing Paper operates a platform focused on enhancing access to cosmetic surgery services while promoting transparency and affordability. The company utilizes information and communication technology to provide patients with estimates for necessary procedures, honest reviews, and special pricing options. In addition to connecting patients with cosmetic treatment options, Healing Paper fosters a real-time community for sharing experiences and offers management tools for post-surgery care. By balancing information between medical professionals and patients, Healing Paper aims to improve the quality of cosmetic beauty services and make them more accessible.

Harbour BioMed

Series B in 2020
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Nanovision

Series B in 2019
Nanovision Technology is located in Zhongguancun Yongfeng high-tech industrial base, with thousands of square meters of R&D foundation in Yonyou Industrial Park. We also set up a subsidiary company in Chengdu. their company is a high-tech enterprise focused on high-speed and high-precision radiology imaging.Nanovison focus in static CT,x-ray CMOS detectors and x-ray imaging software, etc.Which can be widely used in medical, industrial, security and other fields.

RT-Thread

Series B in 2019
RT-Thread was born in 2006, it is an open source, neutral, and community-based real-time operating system (RTOS). RT-Thread is mainly written in C language, easy to understand and easy to port(can be quickly ported to a wide range of mainstream MCUs and module chips). It applies object-oriented programming methods to real-time system design, making the code elegant, structured, modular, and very tailorable. RT-Thread has a Standard version and Nano version. For resource-constrained microcontroller (MCU) systems, the NANO kernel version that requires only 3KB Flash and 1.2KB RAM memory resources can be tailored with easy-to-use tools; And for resource-rich IoT devices, RT-Thread can use the on-line software package management tool, together with system configuration tools, to achieve intuitive and rapid modular cutting, seamlessly import rich software packages, thus achieving complex functions like Android's graphical interface and touch sliding effects, smart voice interaction effects, and so on.

Xbiome

Series B in 2019
Xbiome is a pioneering pharmaceutical company in China focused on intestinal micro-ecology, utilizing artificial intelligence to enhance gut health management for a population of 1.3 billion. The company specializes in developing microbial pharmaceuticals aimed at treating microecological intestinal disorders. By analyzing both patient and donor intestinal flora, Xbiome accelerates the creation of effective treatments. Their innovative approach includes the use of living biological drugs and microbial small molecule modulators, which aim to provide patients with relief from various gastrointestinal diseases.

dMed

Series B in 2019
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies. Its business covers consulting, regulatory affairs & strategy, early clinical development, clinical science & medical affairs, clinical operations, biostatistics & programming, data management, drug safety & pharmacovigilance, quality assurance, and information solutions. dMed has set up offices in major cities, including Shanghai, Beijing, Wuhan, New York, Washington, San Francisco, and Brussels, and it employs around 600 professionals globally, among them 60% holds master above degree and 25% with more than 10 years working experiences.

QANDA(Mathpresso)

Series B in 2019
With the mission to provide the most effective education for all, QANDA(Mathpresso) operates the world’s leading learning platform, QANDA, an AI-based learning app that allows students of all levels to receive instant answers and customized learning sources. Recognized for its technological advances, QANDA(Mathpresso) was selected as GSV Edtech 150, national representative of Google AI for Social Good APAC event in 2018, and guest speaker at AWS Public Sector Summit ASEAN in 2019. Since 2015, QANDA(Mathpresso) has raised over $105 million in total from investors including SoftBank Ventures Asia, Legend Capital, Mirae Asset Investment, GGV, and Goodwater Capital. Headquartered in Seoul, QANDA(Mathpresso) has offices in Tokyo, Hanoi, Jakarta, and Bangkok.

GalaxySpace

Series B in 2019
GalaxySpace is a satellite manufacturer based in Haidian, China, founded in 2016. The company specializes in developing and building a low Earth orbit (LEO) broadband satellite constellation and a 5G communication network. GalaxySpace offers various satellite applications, including monitoring systems for airports, parking, and oil reserves, as well as land assessment services. Their product range includes communication payloads, phased array antennas, power management systems, solar panels, and core platform components. Additionally, the company provides one-stop artificial intelligence satellite launch services, facilitating convenient communication and information access for clients while reducing network costs.

AgotoZ

Series B in 2019
AgotoZ Technology, established in 2017 as Guanmai Technology (Beijing) Co., Ltd., specializes in providing high-speed network transmission services tailored for enterprises. The company focuses on WAN high-speed transmission core technology, big data computing, and security defense solutions. By leveraging its capabilities in resource calculation and security, AgotoZ aims to enhance the efficiency and interoperability of enterprise networks. Through independent research and development, it offers advanced technologies and products designed to meet the evolving needs of businesses seeking reliable and efficient network transmission solutions.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Inossem is a technology company dedicated to aiding organizations in their digital transformation efforts, with a primary focus on enhancing operational efficiency and fostering business growth. Headquartered in Montreal, Quebec, Inossem Canada operates as a subsidiary and provides consulting services across the country, specializing in research and development for enterprise applications. Its offerings include corporate advisory services, digital supply chain solutions, and digital workforce tools. The digital supply chain segment features products like InStock, an intelligent storage solution, and InData, which focuses on master data management, both leveraging AI and IoT technologies. Additionally, Inossem's supply chain optimization product, InoVAT, aims to enhance warehouse and inventory management capabilities. In the realm of digital workforce solutions, ProcessGo facilitates rapid data and process integration through automation, providing clients with streamlined operational capabilities. Through its innovative products and services, Inossem supports organizations in achieving sustainable growth by leveraging industry-specific insights and global digital practices.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service provider specializing in solutions for the food industry, particularly catering businesses. Established in June 2011 and headquartered in Beijing, China, the company offers a comprehensive range of services that include sales, procurement, production, quality assurance, warehousing, and transportation. Shuhai operates a modern cold chain logistics center and food processing plants, ensuring the delivery of fresh and high-quality ingredients to restaurant owners. Recognized by industry authorities and customers alike, Shuhai has emerged as a benchmark enterprise in the supply chain field, highlighting its commitment to excellence in service delivery.

Jiangrongxin Technology

Series B in 2019
Jiangrongxin Technology specializes in developing financial and marketing software tailored for consumer financial services enterprises. The company offers a credit card core system designed to assist card issuers in managing cardholder credit and incentives effectively. Additionally, Jiangrongxin Technology provides a marketing platform that facilitates purchase recommendations to consumers and enables the tracking of user retention, thereby enhancing customer engagement and loyalty.

River Security

Series B in 2019
River Security specializes in advanced cybersecurity solutions, focusing on fraud risk protection and dynamic application security. Established in 2012 with headquarters in Shanghai, Beijing, and Shenzhen, the company has developed innovative technologies that enhance the security of corporate website applications and safeguard business data. Its dynamic security bot-gate product utilizes a unique approach to predict server behavior by transforming the underlying code of web pages, allowing for more efficient and timely defenses against various modern cyber attacks. This technology represents a significant departure from traditional security methods, enabling businesses to reduce deployment and operational costs while improving overall security effectiveness.

Black Sesame Technologies

Series B in 2019
Black Sesame Technologies is an AI digital imaging technology firm founded in 2016, with locations in Silicon Valley and Shanghai. The company specializes in developing solutions for real-world AI challenges, focusing on image processing, computing images, and embedded sensing platforms. It provides advanced algorithms for applications in smartphones, autonomous driving, and various consumer electronics. The firm conducts extensive research and development, including core algorithm development, ASIC design, and software systems for advanced driver-assistance systems (ADAS). Black Sesame Technologies is committed to innovation, quality, and reliable service, leveraging the extensive industry experience of its team members. The company has designed automotive-grade system-on-chips (SoCs), including the high-computing Huashan Series and the cross-domain Wudang Series, aimed at enhancing intelligent vehicle solutions and driving the future of mobility.

Likechuxing

Series B in 2019
Traveling immediately is a car sharing travel service platform taking advantage of the tide of sharing economy. By deep integration of mobile Internet and car time-sharing, it breaks the traditional car travel mode and serves the needs of short-haul travel within the city. Travel APP immediately combines the depth of the mobile Internet with the time-sharing of cars. The user can realize the intelligent operation of the whole process of the car at any time through the APP, and only need to bear the mileage and long-term cost. “Travel immediately” changed the way traditional car trips and car rentals.

Tenry Pharmaceutical

Series B in 2019
Shanghai Tenry Pharmaceutical Company Limited operates two advanced manufacturing facilities in Shanghai, specializing in the production of biopharmaceuticals, pharmaceutical raw materials, and chemical drugs. The company is recognized as a technology-driven enterprise, focusing on the development and commercialization of innovative healthcare solutions. Tenry holds 73 nationally approved drugs and two biological agents, with its primary products aimed at bleeding and wound management. Through its commitment to research and development, along with regulatory compliance, Tenry strives to enhance patient care by providing effective treatment options.

Harbour BioMed

Series B in 2018
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Urotronic

Series B in 2018
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, that specializes in developing innovative solutions for urology. Founded in 2014, the company focuses on its flagship product, Optilume, a drug-coated balloon (DCB) catheter designed to treat urethral strictures in men. This minimally invasive device combines balloon dilation with localized drug delivery, utilizing paclitaxel to prevent the recurrence of strictures by limiting cell proliferation and fibrotic scar tissue formation. Urotronic aims to provide urologists and patients with a cost-effective alternative to traditional treatment methods, improving outcomes for individuals suffering from urinary tract conditions.

Spacety

Series B in 2018
Spacety is a microsatellite start-up that specializes in developing commercial micro/nano-satellites. It provides short-cycle, low-cost, and one-stop services to scientists, research institutes, and commercial companies, for science experiments and technology demonstrations. At present, the company has launched four commercial microsatellites and aims for more in the future. The company was founded in January 2016 with headquarters in Changsha, China.

Lunit

Series B in 2018
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company develops solutions for various medical imaging modalities, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. Lunit aims to enhance clinical decision-making for physicians by leveraging machine learning technology to provide accurate and consistent diagnoses. Its product offerings include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which includes AI-powered biomarkers for immuno-oncology. Lunit's deep learning technology has been recognized for its capabilities, ranking among the top in prestigious image recognition competitions, highlighting its innovative approach to processing medical imaging data and utilizing weakly labeled data for improved pattern recognition.

Aikucun

Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.

Renderbus

Series B in 2018
Renderbus provides vertical cloud computing SaaS services for the vision industry.

Paixue Che

Series B in 2018
Pai Xueche is an Internet driving training platform. The school adopts a consultant tracking system throughout the process. The company will equip each student with an exclusive learning car consultant, from registration to the student's driver's license, the whole process of tracking.

Nattitude

Series B in 2018
Nattitude is a retailer focused on developing and selling amino acid-based personal care products aimed at Chinese families. The company offers a range of high-quality and affordable items, including shampoos, cleansing mousses, and shower gels. Nattitude's commitment to natural ingredients is reflected in its product line, which includes subscription-based brands like Zhiguan. The company has secured investments through both angel and A rounds within its first year, highlighting its potential for growth in the consumer products market.

Uditech

Series B in 2018
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

INXX

Series B in 2018
INXX operates an online retail platform that serves as a hub for local and international fashion brands, with a particular emphasis on high-end professional sportswear. The platform is designed to cater to fashion leaders and artists, providing them access to a diverse range of fashionable clothing and accessories. By bringing together artists, designers, and creators from various fields, INXX promotes street-wear culture in China, enabling consumers to discover and purchase high-quality fashion products efficiently. The company aims to create a trendy environment that fosters collaboration and innovation within the fashion industry.

Kunya Medical

Series B in 2018
Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.

Yanwen Express

Series B in 2017
Beijing YANWEN Logistics.Co.,Ltd is a specialized logistics company which was founded with the approval of the relevant competent government department, mainly including the International Logistics Department and the Department of Express, and each of them provide customized services to meet the need of different customers. From a small package to the goods of various forms and sizes, YANWEN Logistics is capable of serving customers by using aircraft, train, automobile and other transport tools with a professional transport management.

Taihe Music Group

Series B in 2017
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.

Immunochina

Series B in 2017
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

WeShine

Series B in 2017
WeShine is a Chinese gif picture sharing platform. The company claims that its service has covered over 800 million Chinese web users and its market share in Chinese GIF search engine has exceeded 90%.

Qian Qian Music

Series B in 2017
Qian Qian Music is an online music platform.

Vingoo Juice

Series B in 2017
Vingoo Juice specializes in creating autonomous machines designed for producing fresh orange juice, primarily targeting the community market in China. By employing a "whole fruit extraction" method, these machines maximize juice yield from each orange, providing customers with enhanced value. The company integrates advanced technologies such as cloud computing, artificial intelligence, and mobile payment systems to elevate the consumer experience, making the process of obtaining fresh juice both intuitive and efficient.

Bellen

Series B in 2017
Bellen Chemistry is a premier provider of a variety of heterocycles. Our activity is focused on the design and development of novel molecules,6361413375267061158256368.jpgintermediates for the Chemical and Pharmaceutical industries. Bellen Chemistryhas a strong R&D team with a talent pool of 200+ trained scientists. We have excellent track records, as we deliver unrivalled chemical innovation to our customers worldwide.

Ucpaas

Series B in 2017
Ucpaas is a provider of cloud communication services based in Shenzhen, China, focused on developing an open platform for converged communication solutions. The company offers a comprehensive cloud computing platform that integrates the capabilities of major telecommunications operators and Internet networks. By utilizing open REST APIs and client SDKs for various operating systems, Ucpaas enables developers and businesses to easily implement voice, SMS, VoIP, and video communication solutions without the burden of hardware or network costs. With over a decade of experience in the VoIP communications industry, Ucpaas has amassed a large user base and holds a significant share of telecommunications resources. The company's specialized team, composed of members with extensive backgrounds in telecommunications and technology, drives innovation and product development, ensuring that Ucpaas remains a competitive player in the digital communication landscape.

Akulaku

Series B in 2017
Akulaku Inc., founded in 2016 and based in Jakarta, Indonesia, is a prominent banking and digital finance platform in Southeast Asia, operating in countries such as Indonesia, the Philippines, and Malaysia. The company focuses on addressing the financial needs of underserved customers in emerging markets by providing a variety of services, including digital banking, financing, investment, and insurance brokerage. Akulaku offers a virtual credit card and an e-commerce platform, along with Asetku, an online wealth management service, and a mobile digital bank known as Neobank, which is supported by Bank Neo Commerce. The company aims to enhance users' shopping experiences by facilitating installment purchases and providing a wide range of virtual payment services, such as mobile top-ups and bill payments. Akulaku's mission is to serve 50 million users across Southeast Asia by 2025.

PhiSkin

Series B in 2017
PhiSkin is a skin and laser clinic based in China, specializing in aesthetic medicine. The clinic offers a range of services, including aesthetic product injections such as Botox and hyaluronic acid, laser treatments, and non-surgical beauty procedures like double eyelid surgery. PhiSkin aims to provide customers with a comprehensive understanding of their skin conditions, along with tailored skincare solutions to meet individual needs.

Bangsun Technology

Series B in 2017
Bangsun Technology is a Hangzhou-based real-time financial risk management company. It provides services including payment anti-fraud, application anti-fraud, Internet lending, data service, robot defense and anti-money laundering for financial institutions.

Qiang Sen International Community Medical

Series B in 2017
Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.